Pharmacists and patients sharing decisions about medicines: Development and feasibility of a conversation guide

Kristie Rebecca Weir(Primary Health Care), Jesse Jansen(The University of Sydney), Vasi Naganathan(The University of Sydney), Lyndal Trevena(The University of Sydney), Andrew J. McLachlan(The University of Sydney), Kirsten McCaffery(New South Wales Department of Health), Stacy M. Carter(University of Wollongong), Carissa Bonner(The University of Sydney), Debbie Rigby(Queensland University of Technology)

Research in Social and Administrative Pharmacy

August 22, 2018

10.1016/j.sapharm.2018.08.009

Cited by 32

Related Papers

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

|The Lancet|2012|12k

Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes

|Journal of Clinical Epidemiology|2012|1.2k

Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials

|BMJ|2015|577

Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis

|BMJ Open|2016|527

Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies

|Thrombosis and Haemostasis|2014|467